Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

Mitochondrion

Volumn 6, Issue 1, 2006, Pages 1-28

  Begriche, Karima ^a   Igoudjil, Anissa ^a   Pessayre, Dominique ^a   Fromenty, Bernard ^a  

^a INSERM   (France)

Author keywords

Cytokines; Lipid peroxidation; Mitochondria; Reactive oxygen species; Steatohepatitis; Steatosis

Indexed keywords

ALDEHYDE DERIVATIVE; ALPHA TOCOPHEROL; AMIODARONE; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; CYTOCHROME P450 2E1; CYTOKINE; DIDANOSINE; FAS LIGAND; FATTY ACID DERIVATIVE; FIBRIC ACID DERIVATIVE; INSULIN; MALONALDEHYDE; METFORMIN; MITOCHONDRIAL DNA; PERHEXILINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROBUCOL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; STAVUDINE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2; UNINDEXED DRUG; ZIDOVUDINE;

APOPTOSIS; CELL CYCLE; CELL DEATH; CELL ENERGY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID OXIDATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; LIVER CELL DAMAGE; LIVER MITOCHONDRION; MITOCHONDRIAL DNA REPLICATION; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 32844458032     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2005.10.004     Document Type: Review

References (345)

1. A. Abbey-Toby K. Begriche A. Igoudjil P. Lettéron S. Dubois B. Fromenty β-Aminoisobutyric acid alleviates steatohepatitis in a murine model of diabetes and obesity Virchows Arch. 447 2005 305
2. M.F. Abdelmalek P. Angulo R.A. Jorgensen P.B. Sylvestre K.D. Lindor Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study Am. J. Gastroenterol. 96 2001 2711-2717
3. L.A. Adams C.O. Zein P. Angulo K.D. Lindor A pilot trial of pentoxifylline in nonalcoholic steatohepatitis Am. J. Gastroenterol. 99 2004 2365-2368
4. K.G. Alberti P. Zimmet J. Shaw IDF epidemiology task force consensus group, the metabolic syndrome: A new worldwide definition Lancet 366 2005 1059-1062
5. N. Andrieu-Abadie J.P. Jaffrezou S. Hatem G. Laurent T. Levade J.J. Mercadier l-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation Fed. Am. Soc. Exp. Biol. J. 13 1999 1501-1510
6. P. Angulo Nonalcoholic fatty liver disease N. Engl. J. Med. 346 2002 1221-1231
7. D.A. Antonetti C. Reynet C.R. Kahn Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus J. Clin. Invest. 95 1995 1383-1388
8. T. Armeni C. Pieri M. Marra F. Saccucci G. Principato Studies on the life prolonging effect of food restriction: Glutathione levels and glyoxalase enzymes in rat liver Mech. Ageing Dev. 101 1998 101-110
9. A.D. Attie R.M. Krauss M.P. Gray-Keller A. Brownlie M. Miyazaki J.J. Kastelein A.J. Lusis A.F. Stalenhoef J.P. Stoehr M.R. Hayden J.M. Ntambi Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia J. Lipid Res. 43 2002 1899-1907
10. F. Azzaroli W. Mehal C.J. Soroka L. Wang J. Lee N. Crispe J.L. Boyer Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes Hepatology 36 2002 49-54
11. G. Baffy C.Y. Zhang J.N. Glickman B.B. Lowell Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2 Hepatology 35 2002 753-761
12. M. Barile D. Valenti S. Passarella E. Quagliariello 3′-Azido-3′deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator Biochem. Pharmacol. 53 1997 913-920
13. C.R. Barnett R.A. Abbott C.J. Bailey P.R. Flatt C. Ionnides Cytochrome P450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes Biochem. Pharmacol. 43 1992 1868-1871
14. P.B. Bartley L. Westacott R.J. Boots M. Lawson J.M. Potter V.J. Hyland M.L. Woods Large hepatic mitochondrial DNA deletions associated with l -lactic acidosis and highly active antiretroviral therapy Acquir Immune Defic Syndr. 15 2001 419-420
15. M. Basaranoglu O. Acbay A. Sonsuz A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis J. Hepatol. 31 1999 384
16. K. Begriche A. Igoudjil A. Abbey-Toby C. Maisonneuve P. Lettéron D. Pessayre B. Fromenty A thymine catabolite, β-aminoisobutyric acid, reduces hepatic dysfunction and metabolic disorders in overweight or obese mice J. Hepatol. 42 Suppl. 2 2005 243
17. K. Beier A. Volkl H.D. Fahimi TNF-α downregulates the peroxisome proliferator activated receptor-α and the mRNAs encoding peroxisomal proteins in rat liver Fed. Eur. Biochem. Soc. Lett. 412 1997 385-387
18. S. Bellentani G. Saccoccio F. Masutti L.S. Croce G. Brandi F. Sasso G. Cristanini C. Tiribelli Prevalence and risk factors for hepatic steatosis in northern Italy Ann. Intern. Med. 132 2000 112-117
19. B.L. Bennett Y. Satoh A.J. Lewis JNK: A new therapeutic target for diabetes Curr. Opin. Pharmacol. 3 2003 420-425
20. A.H. Berg T.P. Combs P.E. Scherer ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism Trends Endocrinol. Metab. 13 2002 84-89
21. M. Berneburg S. Grether-Beck V. Kürten T. Ruzicka K. Briviba H. Sies J. Krutmann Singlet oxygen mediates the UVA-induced generation of photoaging-associated mitochondrial common deletion J. Biol. Chem. 274 1999 15345-15349
22. A. Berson V. De Beco P. Lettéron M.A. Robin C. Moreau J. El Kahwaji N. Verthier G. Feldmann B. Fromenty D. Pessayre Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes Gastroenterology 114 1998 764-774
23. D.F. Bogenhagen Repair of mtDNA in vertebrates Am. J. Hum. Genet. 64 1999 1276-1281
24. A. Bouloumie T. Marumo M. Lafontan R. Busse Leptin induces oxidative stress in human endothelial cells Fed. Am. Soc. Exp. Biol. J. 13 1999 1231-1238
25. M. Bouskila U.B. Pajvani P.E. Scherer Adiponectin: A relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity? Int. J. Obes. Relat. Metab. Disord. 29 Suppl 1 2005 S17-S23
26. L.J. Brady P.S. Brady D.R. Romsos C.L. Hoppel Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice Biochem. J. 231 1985 439-444
27. G.A. Bray S.J. Nielsen B.M. Popkin Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity Am. J. Clin. Nutr. 79 2004 537-543
28. K. Brinkman H.J.M. ter Hofstede D.M. Burger J.A. Smeitink P.P. Koopmans Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway Acquiro Immune Defic. Syndr. 12 1998 1735-1744
29. J.D. Browning J.D. Horton Molecular mediators of hepatic steatosis and liver injury J. Clin. Invest. 114 2004 147-152
30. B. Brunmair K. Staniek F. Gras N. Scharf A. Althaym R. Clara M. Roden E. Gnaiger H. Nohl W. Waldhausl C. Furnsinn Thiazolidinediones, like metformin, inhibit respiratory complex I: A common mechanism contributing to their antidiabetic actions? Diabetes 53 2004 1052-1059
31. S. Bruno P. Maisonneuve P. Castellana N. Rotmensz S. Rossi M. Maggioni M. Persico A. Colombo F. Monasterolo D. Casadei-Giunchi F. Desiderio T. Stroffolini V. Sacchini A. Decensi U. Veronesi Incidence and risk factors for non-alcoholic steatohepatitis: Prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial (published 21 March 2005) Br. Med. J. (online) 2005 10.1136/bmj.38391.663287.E0
32. I. Bykov H. Jarvelainen K. Lindros l-carnitine alleviates alcohol-induced liver damage in rats: Role of tumour necrosis factor-α Alcohol Alcohol 38 2003 400-406
33. A. Cabrero M. Alegret R.M. Sanchez T. Adzet J.C. Laguna M.V. Carrera Increased reactive oxygen species production down-regulates peroxisome proliferator-activated α pathway in C2C12 skeletal muscle cells J. Biol. Chem. 277 2002 10100-10107
34. A. Cahill C.C. Cunningham H. Ishii S.M. Bailey B. Fromenty A. Davies Effects of alcohol and oxidative stress on liver pathology: The role of the mitochondrion Alcohol Clin. Exp. Res. 26 2002 907-915
35. Y. Cai B.D. Nelson R. Li K. Luciakova J.W. dePierre Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis Arch. Biochem. Biophys. 325 1996 107-112
36. S.H. Caldwell R.H. Swerdlow E.M. Khan J.C. Iezzoni E.E. Hespenheide J.K. Parks W.D. Parker Mitochondrial abnormalities in nonalcoholic steatohepatitis J. Hepatol. 31 1999 430-434
37. C.M.P. Cardoso J.B.A. Custodio L.M. Almeida A.J.M. Moreno Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency Toxicol. Appl. Pharmacol. 176 2001 145-152
38. M.C. Carmona K. Louche M. Nibbelink B. Prunet A. Bross M. Desbazeille C. Dacquet P. Renard L. Casteilla L. Penicaud Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice Int. J. Obes. Relat. Metab. Disord. 29 2005 864-871
39. M.V. Chakravarthy Z. Pan Y. Zhu K. Tordjman J.G. Schneider T. Coleman J. Turk C.F. Semenkovich 'New' hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis Cell Metab. 1 2005 309-322
40. N. Chalasani J.C. Gorski M.S. Asghar A. Asghar B. Foresman S.D. Hall D.W. Crabb Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis Hepatology 37 2003 544-550
41. B. Chang M. Nishikawa E. Sato K. Utsumi M. Inoue L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine Arch. Biochem. Biophys. 405 2002 55-64
42. F.F. Chao D.L. Stiers J.A. Ontko Hepatocellular triglyceride synthesis and transfer to lipid droplets and nascent very low density lipoproteins J. Lipid Res. 27 1986 1174-1181
43. L. Chao B. Marcus-Samuels M.M. Mason J. Moitra C. Vinson E. Arioglu O. Gavrilova M.L. Reitman Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones J. Clin. Invest. 106 2000 1221-1228
44. P. Chariot I. Drogou I. de Lacroix-Szmania M.C. Eliezer-Vanerot B. Chazaud A. Lombes A. Schaeffer E.S. Zafrani Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion J. Hepatol. 30 1999 156-160
45. M. Charlton R. Sreekumar D. Rasmussen K. Lindor S. Nair Apolipoprotein synthesis in nonalcoholic steatohepatitis Hepatology 35 2002 898-904
46. K.D. Chavin S. Yang H.Z. Lin J. Chatham V.P. Chacko J.B. Hoek E. Walajtys-Rode A. Rashid C.H. Chen C.C. Huang T.C. Wu M.D. Lane A.M. Diehl Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion J. Biol. Chem. 274 1999 5692-5700
47. J. Chen S. Schenker T.A. Frosto G.I. Hensderson Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme catalytic site Biochem. Biophys. Acta 11380 1998 336-344
48. J. Chen D.R. Petersen S. Schenker G.I. Hensderson Formation of malondialdehyde adducts in livers of rats exposed to ethanol: Role of ethanol-mediated inhibition of cytochrome c oxidase Alcohol. Clin. Exp. Res. 24 2000 544-552
49. M.B. Chen A.J. McAinch S.L. Macaulay L.A. Castelli P.E. O'brien J.B. Dixon D. Cameron-Smith B.E. Kemp G.R. Steinberg Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle from obese type 2 diabetics J. Clin. Endocrinol. Metab. 90 2005 3665-3672
50. S. Chitturi G.C. Farrell Etiopathogenesis of nonalcoholic steatohepatitis Semin. Liver Dis. 21 2001 27-41
51. S. Chitturi S. Abeygunasekera G.C. Farrell J. Holmes-Walker J.M. Hui C. Fung R. Karim R. Lin D. Samarasinghe C. Liddle M. Weltman J. George NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance Hepatology 35 2002 373-379
52. S. Chitturi G.C. Farrell L. Frost A. Kriketos R. Lin C. Liddle D. Samarasinghe J. George Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? Hepatology 36 2002 403-409
53. C.J. Chou M. Haluzik C. Gregory K.R. Dietz C. Vinson O. Gavrilova M.L. Reitman WY14,643, a peroxisome proliferator-activated receptor-α (PPARα) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice J. Biol. Chem. 277 2002 24484-24489
54. W.K. Chung K. Belfi M. Chua J. Wiley R. Mackintosh M. Nicolson C.N. Boozer R.L. Leibel Heterozygosity for Lep(ob) or Lep(rdb) affects body composition and leptin homeostasis in adult mice Am. J. Physiol. 274 4 Pt 2 1998 R985-R990
55. M.E. Coglan P. Sommadossi N.C. Jhala W.J. Many M.S. Saag V.A. Johnson Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases Clin. Infect. Dis. 33 2001 1914-1921
56. J.R. Colca W.G. McDonald D.J. Waldon J.W. Leone J.M. Lull C.A. Bannow E.T. Lund W.R. Mathews Identification of a novel mitochondrial protein ('mitoNEET') cross-linked specifically by a thiazolidinedione photoprobe Am. J. Physiol. Endocrinol. Metab. 286 2004 E252-E260
57. J.C. Collins I.H. Scheinberg D.R. Giblin I. Sternlieb Hepatic peroxisomal abnormalities in abetalipoproteinemia Gastroenterology 97 1989 766-770
58. G.A. Cook M.S. Gamble Regulation of carnitine palmitoyltransferase by insulin results in decreased activity and decreased apparent Ki values for malonyl-CoA J. Biol. Chem. 262 1987 2050-2055
59. S. Corda C. Laplace E. Vicaut J. Duranteau Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-α is mediated by ceramide Am. J. Respir. Cell Mol. 24 2001 762-768
60. H. Cortez-Pinto A. Baptista M.E. Camilo E.B. de Costa A. Valente M.C. de Moura Tamoxifen-associated steatohepatitis- report of three cases J. Hepatol. 23 1995 95-97
61. H. Cortez-Pinto J. Chatham V.P. Chacko C. Arnold A. Rashid A.M. Diehl Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis. A pilot study J. Am. Med. Assoc. 282 1999 1659-1664
62. J. Crespo A. Cayon P. Fernandez-Gil M. Hernandez-Guerra M. Mayorga A. Dominguez-Diez J.C. Fernandez-Escalante F. Pons-Romero Gene expression of tumor necrosis factor α and TNF-receptors p55 and p75 in nonalcoholic steatohepatitis patients Hepatology 34 2001 1158-1163
63. D.L. Croteau R.H. Stierum V.A. Bohr Mitochondrial DNA repair pathways Mutat. Res. 434 1999 137-148
64. J.W. Crott S.W. Choi R.F. Branda J.B. Mason Accumulation of mitochondrial DNA deletions is age, tissue and folate-dependent in rats Mutat. Res. 570 2005 63-70
65. A. Dayanandan P. Kumar C. Panneerselvam Protective role of l-carnitine on liver and heart lipid peroxidation in atherosclerotic rats J. Nutr. Biochem. 12 2001 254-257
66. D. De Craemer M. Pauwels C. Van den Branden Alterations of peroxisomes in steatosis of the human liver: A quantitative study Hepatology 22 1995 744-752
67. J.G. de la Asuncion A. Millan R. Pla L. Bruseghini A. Esteras F.V. Pallardo J. Sastre J. Vina Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA Fed. Am. Soc. Exp. Biol. J. 10 1996 333-338
68. J.G. de la Asuncion M.L. del Olmo J. Sastre A. Millan A. Pellin F.V. Pallardo J. Vina AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins J. Clin. Invest. 102 1998 4-9
69. F. Degoul A. Sutton A. Mansouri C. Cepanec C. Degott B. Fromenty M. Beaugrand D. Valla D. Pessayre Homozygosity for alanine in the mitochondrial targeting sequence of manganese superoxide dismutase and alcohol liver disease Gastroenterology 120 2001 1468-1474
70. P. Delerive P. Gervois J.C. Fruchart B. Staels Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators J. Biol. Chem. 275 2000 36703-36707
71. C. Demeilliers C. Maisonneuve A. Grodet A. Mansouri R. Nguyen M. Tinel P. Lettéron C. Degott G. Feldmann D. Pessayre B. Fromenty Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice Gastroenterology 123 2002 1278-1290
72. Y. Deng X. Ren L. Yang Y. Lin X. Wu A JNK-dependent pathway is required for TNF-α-induced apoptosis Cell 115 2003 61-70
73. R. Dentin J.P. Pegorier F. Benhamed F. Foufelle P. Ferre V. Fauveau M.A. Magnuson J. Girard C. Postic Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression J. Biol. Chem. 279 2004 20314-20326
74. D. Deschamps V. De Beco C. Fisch B. Fromenty A. Guillouzo D. Pessayre Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: Possible role in pseudoalcoholic liver lesions Hepatology 19 1994 948-961
75. A.M. Diehl Nonalcoholic steatohepatitis Semin. Liver Dis. 19 1999 221-229
76. J.J. Diez P. Iglesias The role of the novel adipocyte-derived hormone adiponectin in human disease Eur. J. Endocrinol. 148 2003 293-300
77. W.X. Ding X.M. Yin Dissection of the multiple mechanisms of TNF-α-induced apoptosis in liver injury J. Cell. Mol. Med. 8 2004 445-454
78. W.X. Ding H.M. Ni D. DiFrancesca D.B. Stolz X.M. Yin Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes Hepatology 40 2004 403-413
79. F. Diraison V. Yankah D. Letexier E. Dusserre P. Jones M. Beylot Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans J. Lipid Res. 44 2003 846-853
80. J.B. Dixon P.S. Bhathal P.E. O'Brien Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 2001 91-100
81. N.M. Druzhyna S.I. Musiyenko G.L. Wilson S.P. LeDoux Cytokines induce nitric oxide-mediated mtDNA damage and apoptosis in oligodendrocytes. Protective role of targeting o-oxoguanine glycosylase to mitochondria J. Biol. Chem. 280 2005 21673-21679
82. X.L. Du D. Edelstein L. Rossetti I.G. Fantus H. Goldberg F. Ziyadeh J. Wu M. Brownlee Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation Proc. Natl Acad. Sci. USA 97 2000 12222-12226
83. P.H. Ducluzeau A. Lachaux R. Bouvier N. Streichenberger G. Stepien B. Mousson Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis J. Hepatol. 30 1999 149-155
84. P.H. Ducluzeau A. Lachaux R. Bouvier H. Duborjal G. Stepien D. Bozon B. Mousson de Camaret Progressive reversion of clinical and molecular phenotype in a child with liver mitochondrial DNA depletion J. Hepatol. 36 2002 698-703
85. J.F. Dufour C. Oneta J.J. Gonvers F. Bihl A. Cerny J.M. Cereda J.F. Zala B. Helbling M. Steuerwald A. Zimmermann A 2-years multicenter randomized placebo-controlled study testing UDCA in combination with vitamin E to treat NASH J. Hepatol. 42 Suppl. 2 2005 4-5
86. K.S. Echtay M.P. Murphy R.A. Smith D.A. Talbot M.D. Brand Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants J. Biol. Chem. 277 2002 47129-47135
87. R.H. Eckel S.M. Grundy P.Z. Zimmet The metabolic syndrome Lancet 365 2005 1415-1428
88. A. Elimadi D. Morin E. Albengres A.M. Chauvet-Monges V. Allain A. Crevat J.P. Tillement Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation Br. J. Pharmacol. 121 1997 1295-1300
89. N. Enomoto Y. Takei M. Hirose K. Ikejima H. Miwa T. Kitamura N. Sato Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-α production Gastroenterology 123 2002 291-300
90. Y. Falck-Ytter Z.M. Younossi G. Marchesini A.J. McCullough Clinical features and natural history of nonalcoholic steatosis syndromes Semin. Liver Dis. 21 2001 17-26
91. J.G. Fan L. Zhong L.Y. Tia Z.J. Xu M.S. Li G.L. Wang Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia World J. Gastroenterol. 11 2005 2346-2350
92. M.W. Fariss F.A. Nicholls-Grzemski M.A. Tirmenstein J.G. Zhang Enhanced antioxidant and cytoprotective abilities of vitamin E succinate is associated with a rapid uptake advantage in rat hepatocytes and mitochondria Free Radic. Biol. Med. 31 2001 530-541
93. I.S. Farooqi J.M. Keogh S. Kamath S. Jones W.T. Gibson R. Trussell S.A. Jebb G.Y. Lip S. O'Rahilly Partial leptin deficiency and human adiposity Nature 414 2001 34-35
94. G.C. Farrell Drugs and steatohepatitis Semin. Liver Dis. 22 2002 185-194
95. K.R. Feingold C. Grunfeld Tumor necrosis factor-α stimulates hepatic lipogenesis in the rat in vivo J. Clin. Invest. 80 1987 184-190
96. A.E. Feldstein A. Canbay P. Angulo M. Taniai L.J. Burgart K.D. Lindor G.J. Gores Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 125 2003 437-443
97. J.C. Fernandez-Checa N. Kaplowitz Hepatic mitochondrial glutathione: transport and role in disease and toxicity Toxicol. Appl. Pharmacol. 204 2005 263-273
98. R.N. Fiorini S.F. Shafizadeh K.D. Chavin Primary non-function in steatotic livers is due to differential Toll-like expression and endotoxin sensitivity Hepatology 36 2002 198
99. C. Fleury D. Sanchis The mitochondrial uncoupling protein-2: Current status Int. J. Biochem. Cell Biol. 31 1999 1261-1278
100. M. Foretz D. Carling C. Guichard P. Ferre F. Foufelle AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes J. Biol. Chem. 273 1998 14767-14771
101. J.M. Friedman J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763-770
102. B. Fromenty D. Pessayre Inhibition of mitochondrial ß-oxidation as a mechanism of hepatotoxicity Pharmacol. Ther. 67 1995 101-154
103. B. Fromenty C. Fisch G. Labbe C. Degott D. Deschamps A. Berson P. Lettéron D. Pessayre Amiodarone inhibits the mitochondrial β-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice J. Pharmacol. Exp. Ther. 255 1990 1371-1376
104. B. Fromenty C. Fisch A. Berson P. Lettéron D. Larrey D. Pessayre Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and II J. Pharmacol. Exp. Ther. 255 1990 1377-1384
105. B. Fromenty P. Lettéron C. Fish A. Berson D. Deschamps D. Pessayre Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Effects of low concentrations of amiodarone on fatty acid oxidation, ATP levels and cell survival Biochem. Pharmacol. 45 1993 421-432
106. B. Fromenty S. Grimbert A. Mansouri M. Beaugrand S. Erlinger A. Rotig D. Pessayre Hepatic mitochondrial DNA deletion in alcoholics: Association with microvesicular steatosis Gastroenterology 108 1995 193-200
107. B. Fromenty M.A. Robin A. Igoudjil A. Mansouri D. Pessayre The ins and outs of mitochondrial dysfunction in NASH Diabetes Metab. 30 2004 121-138
108. D. Gao C. Wei L. Chen J. Huang S. Yang A.M. Diehl Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease Am. J. Physiol. Gastrointest. Liver Physiol. 287 2004 G1070-G1077
109. I. Gaou M. Malliti M.C. Guimont P. Lettéron C. Demeilliers G. Peytavin C. Degott D. Pessayre B. Fromenty Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice J. Pharmacol. Exp. Ther. 297 2001 516-523
110. B. Georges S. Galland C. Rigault F. Le Borgne J. Demarquoy Beneficial effects of l-carnitine in myoblastic C2C12 cells. Interaction with zidovudine Biochem. Pharmacol. 65 2003 1483-1488
111. H. Glosli O.A. Gudbrandsen A.J. Mullen B. Halvorsen T.H. Rost H. Wergedahl H. Prydz P. Aukrust R.K. Berge Down-regulated expression of PPARα target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFα Biochim. Biophys. Acta 1734 2005 235-246
112. F.J. Gonzalez Role of cytochromes P450 in chemical toxicity and oxidative stress: Studies with CYP2E1 Mutat. Res. 569 2005 101-110
113. A.A. Gonzalez R. Kumar J.D. Mulligan A.J. Davis R. Weindruch K.W. Saupe Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity Am. J. Physiol. Endocrinol. Metab. 287 2004 E1032-E1037
114. E.S. Gorden Non-esterified fatty acids in blood of obese and lean subjects Am. J. Clin. Nutr. 8 1960 740-747
115. I. Grattagliano P. Portincasa T. Cocco A. Moschetta M. Di Paola V.O. Palmieri G. Palasciano Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats Exp. Gerontol. 39 2004 1323-1332
116. O.W. Griffith β-Amino acids: Mammalian metabolism and utility as α-amino acid analogues Annu. Rev. Biochem. 55 1986 855-878
117. M. Guerre-Millo Adipose tissue and adipokines: For better or worse Diabetes Metab. 30 2004 13-19
118. B. Guigas D. Detaille C. Chauvin C. Batandier F. De Oliveira E. Fontaine X. Leverve Metformin inhibits mitochondrial permeability transition and cell death: A pharmacological in vitro study Biochem. J. 382 2004 877-884
119. E. Gumpricht M.W. Devereaux M. Traber R.J. Sokol Enrichment of rat hepatic organelles by vitamin E administered subcutaneously Free Radic. Biol. Med. 37 2004 1712-1717
120. T.M. Hagen D.L. Yowe J.C. Bartholomew C.M. Wehr K.L. Do J.Y. Park B.N. Ames Mitochondrial decay in hepatocytes from old rats: Membrane potential declines, heterogeneity and oxidants increase Proc. Natl Acad. Sci. USA 94 1997 3064-3069
121. T.M. Hagen C.M. Wehr B.N. Ames Mitochondrial decay in aging. Reversal through supplementation of acetyl-l-carnitine and N-tert-butyl-alpha-phenyl-nitrone Ann. NY. Acad. Sci. 854 1998 214-223
122. T.M. Hagen J. Liu J. Lykkesfeldt C.M. Wehr R.T. Ingersoll V. Vinarsky J.C. Bartholomew B.N. Ames Feeding acetyl-l-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress Proc. Natl Acad. Sci. USA 99 2002 1870-1875
123. J. Hager K. Clement S. Francke C. Dina J. Raison N. Lahlou N. Rich V. Pelloux A. Basdevant B. Guy-Grand M. North P. Froguel A polymorphism in the 5' untranslated region of the human ob gene is associated with low leptin levels Int. J. Obes. Relat. Metab. Disord. 22 1998 200-205
124. M. Hamdan S. Urien H. Le Louet J.P. Tillement D. Morin Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176 Pharmacol. Res. 44 2001 99-104
125. D. Haouzi M. Lekehal M. Tinel N. Vadrot L. Caussanel P. Lettéron A. Moreau G. Feldmann D. Fau D. Pessayre Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice Hepatology 33 2001 1181-1188
126. M. Haque F. Mirshahi C. Campbell-Sargent R.K. Sterling V.A. Luketic V.A. Shiffman R.T. Stravitz A.J. Sanyal Nonalcoholic steatohepatitis (NASH) is associated with hepatocyte mitochondrial DNA depletion Hepatology 36 2002 403
127. S.A. Harrison S. Torgerson P. Hayashi J. Ward S. Schenker Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis Am. J. Gastroenterol. 98 2003 2485-2490
128. T. Hasegawa M. Yoneda K. Nakamura I. Makino A. Terano Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: A pilot study Aliment. Pharmacol. Ther. 15 2001 1667-1672
129. K. Hashiguchi V.A. Bohr N.C. de Souza-Pinto Oxidative stress and mitochondrial DNA repair: Implications for NRTIs-induced DNA damage Mitochondrion 4 2004 215-222
130. T. Hassanein Mitochondrial dysfunction in liver disease and organ transplantation Mitochondrion 4 2004 609-620
131. M. Hayakawa T. Ogawa S. Sugiyama M. Tanaka T. Ozawa Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine Biochem. Biophys. Res. Commun. 176 1991 87-93
132. H.W. Heid R. Moll I. Schwetlick H.R. Rackwitz T.W. Keenan Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases Cell Tissue Res. 294 1998 309-321
133. 2 generation in liver mitochondria Carcinogenesis 21 2000 983-989
134. J. Himms-Hagen M.E. Harper Physiological role of UCP-3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: An hypothesis Exp. Biol. Med. 226 2001 78-84
135. J. Hirosumi G. Tuncman L. Chang C.Z. Gorgun K.T. Uysal K. Maeda M. Karin G.S. Hotamisligil A central role for JNK in obesity and insulin resistance Nature 420 2002 353-356
136. J.B. Hoek A. Cahill J.G. Pastorino Alcohol and mitochondria: A dysfunctional relationship Gastroenterology 122 2002 2049-2063
137. G.S. Hotamisligil Inflammatory pathways and insulin action Int. J. Obes. Relat. Metab. Disord. 27 Suppl 3 2003 S53-S55
138. A.M. Hruszkewycz Evidence for mitochondrial DNA damage by lipid peroxidation Biochem. Biophys. Res. Commun. 153 1988 191-197
139. A.M. Hruszkewycz D.S. Bergtold The 8-hydroxyguanine content of isolated mitochondria increases with lipid peroxidation Mutat. Res. 244 1990 123-128
140. B. Hu S.W. French 2′,3′-Dideoxyinosine-induced Mallory bodies in patients with HIV Am. J. Clin. Pathol. 108 1997 280-283
141. G. Hughes M.P. Murphy E.C. Ledgerwood Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor κB to modulate tumour necrosis factor-induced apoptosis: Evidence from mitochondria-targeted antioxidants Biochem. J. 389 2005 83-89
142. R.S. Hundal M. Krssak S. Dufour D. Laurent V. Lebon V. Chandramouli S.E. Inzucchi W.C. Schumann K.F. Petersen B.R. Landau G.I. Shulman Mechanism by which metformin reduces glucose production in type 2 diabetes Diabetes 49 2000 2063-2069
143. J.A. Ibdah P. Perlegas Y. Zhao J. Angdisen H. Borgerink M.K. Shadoan J.D. Wagner D. Matern P. Rinaldo J.M. Cline Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance Gastroenterology 128 2005 1381-1390
144. M. Iemitsu T. Miyauchi S. Maeda T. Tanabe M. Takanashi Y. Irukayama-Tomobe S. Sakai H. Ohmori M. Matsuda I. Yamaguchi Aging-induced decrease in the PPAR-α level in hearts is improved by exercise training Am. J. Physiol. Heart Circ. Physiol. 283 2002 H1750-H1760
145. A. Igoudjil K. Begriche C. Maisonneuve K. Chataigner P. Lettéron M.A. Robin D. Pessayre B. Fromenty Mitochondrial and metabolic disturbances induced by high dose of stavudine in mice are alleviated by coadministration of l-carnitine. Possible role of PPAR-α J. Hepatol. 42 Suppl. 2005 247
146. K. Iizuka R.K. Bruick G. Liang J.D. Horton K. Uyeda Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis Proc. Natl Acad. Sci. USA 101 2004 7281-7286
147. K. Ikejima Y. Takei H. Honda M. Hirose M. Yoshikawa Y.J. Zhang T. Lang T. Fukuda S. Yamashina T. Kitamura N. Sato Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat Gastroenterology 122 2002 1340-1399
148. G.N. Ioannou N. Weiss K.V. Kowdley J.A. Dominitz Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study Gastroenterology 125 2003 1053-1059
149. E. Ip G.C. Farrell G. Robertson P. Hall R. Kirsch I. Leclercq Central role of PPAR-α dependent hepatic lipid turnover in dietary steatohepatitis in mice Hepatology 38 2003 123-132
150. E. Ip G. Farrell P. Hall G. Robertson I. Leclercq Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice Hepatology 39 2004 1286-1296
151. P. Ježek Possible physiological roles of mitochondrial uncoupling proteins-UCPn Int. J. Biochem. Cell Biol. 34 2002 1190-1206
152. Y. Kakimoto K. Taniguchi I. Sano d -β-Aminoisobutyrate:pYruvate aminotransferase in mammalian liver and excretion of β-aminoisobutyrate by man J. Biol. Chem. 244 1969 335-340
153. M. Kakimoto T. Inoguchi T. Sonta H.Y. Yu M. Imamura T. Etoh T. Hashimoto H. Nawata Accumulation of 8-hydroxy-2'-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats Diabetes 51 2002 1588-1595
154. H. Kamata S. Honda S. Maeda L. Chang H. Hirata M. Karin Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases Cell 120 2005 649-661
155. A. Kante M.C. Malki C. Coquard N. Latruffe Metabolic control of the expression of mitochondrial hydroxybutyrate dehydrogenase, a ketone body converting enzyme Biochim. Biophys. Acta 1033 1990 291-297
156. P. Kaufmann M. Torok A. Hanni P. Roberts R. Gasser S. Krahenbuhl Mechanisms of benzarone and benzbromarone-induced hepatic toxicity Hepatology 41 2005 925-935
157. D.E. Kelley J. He E.V. Menshikova V.B. Ritov Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 2002 2944-2950
158. J.A. Kennedy S.A. Unger J.D. Horowitz Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone Biochem. Pharmacol. 52 1996 273-280
159. S. Kersten J. Seydoux J.M. Peters F.J. Gonzalez B. Desvergne W. Wahli Peroxisome proliferator-activated receptor-α mediates the adaptive response to fasting J. Clin. Invest. 103 1999 1489-1498
160. H.I. Kim Y.H. Ahn Role of peroxisome proliferator-activated receptor-γ in the glucose-sensing apparatus of liver and β-cells Diabetes 53 Suppl 1 2004 S60-S65
161. D. Kirpichnikov S.I. McFarlane J.R. Sowers Metformin: An update Ann. Intern. Med. 137 2002 25-33
162. M. Kiyici M. Gulten S. Gurel S.G. Nak E. Dolar G. Savci S.B. Adim O. Yerci F. Memik Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis Can. J. Gastroenterol. 17 2003 713-718
163. J. Kohlroser J. Mathai J. Reichheld B.F. Banner H.L. Bonkovsky Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States food and drug administration Am. J. Gastroenterol. 95 2000 272-276
164. H. Kono I. Rusyn M. Yin E. Gabele S. Yamashina A. Dikalova M.B. Kadiiska H.D. Connor R.P. Mason B.H. Segal B.U. Bradford S.M. Holland R.G. Thurman NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease J. Clin. Invest. 106 2000 867-872
165. P.G. Kopelman Obesity as a medical problem Nature 404 2000 635-643
166. S.W.P. Koppe A. Sahai P. Malladi P.F. Whitington R.M. Green Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet J. Hepatol. 41 2004 592-598
167. A. Koteish A.M. Diehl Animal models of steatosis Semin. Liver Dis. 21 2001 89-104
168. B.S. Kristal B.K. Park B.P. Yu 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition J. Biol. Chem. 271 1996 6033-6038
169. M. Kugelmas D.B. Hill B. Vivian L. Marsano C.J. McClain Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E Hepatology 38 2003 413-419
170. S. Kumaran B. Deepak B. Naveen C. Panneerselvam Effects of levocarnitine on mitochondrial antioxidant systems and oxidative stress in aged rats Drugs R.D. 4 2003 141-147
171. + oxidation-reduction state Biochem. J. 368 2002 545-553
172. A. Lanni F. Mancini L. Sabatino E. Silvestri R. Franco G. De Rosa F. Goglia V. Colantuoni De novo expression of uncoupling protein 3 is associated to enhanced mitochondrial thioesterase-1 expression and fatty acid metabolism in liver of fenofibrate-treated rats Fed. Eur. Biochem. Soc. Lett. 525 2002 7-12
173. A. Laurent C. Nicco J. Tran Van Nhieu D. Borderie C. Chereau F. Conti P. Jaffray O. Soubrane Y. Calmus B. Weill F. Batteux Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis Hepatology 39 2004 1277-1285
174. J. Laurin K.D. Lindor J.S. Crippin A. Gossard G.J. Gores J. Ludwig J. Rakela D.B. McGill Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study Hepatology 23 1996 1464-1467
175. J.E. Lavine Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study J. Pediatr. 136 2000 734-738
176. G. Lazennec L. Canaple D. Saugy W. Wahli Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators Mol. Endocrinol. 14 2000 1962-1975
177. R.M. Lebovitz H. Zhang H. Vogel J. Cartwright L. Dionne N. Lu S. Huang M.M. Matzuk Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice Proc. Natl Acad. Sci. USA 93 1996 9782-9787
178. I.A. Leclercq G.C. Farrell J. Field D.R. Bell F.J. Gonzalez G.R. Robertson CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis J. Clin. Invest. 105 2001 1067-1075
179. I.A. Leclercq G.C. Farrell R. Schriemer G.R. Robertson Leptin is essential for the hepatic fibrogenic response to chronic liver injury J. Hepatol. 37 2002 206-213
180. H.K. Lee J.H. Song C.S. Shin D.J. Park K.S. Park K.U. Lee C.S. Koh Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus Diabetes Res. Clin. Pract. 42 1998 161-167
181. Y. Lee M.Y. Wang T. Kakuma Z.W. Wang E. Babcock K. McCorkle M. Higa Y.T. Zhou R.H. Unger Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia J. Biol. Chem. 276 2001 5629-5635
182. Y. Lee X. Yu F. Gonzales D.J. Mangelsdorf M.Y. Wang C. Richardson L.A. Witters R.H. Unger PPAR-α is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue Proc. Natl Acad. Sci. USA 99 2002 11848-11853
183. P. Lettéron B. Fromenty B. Terris C. Degott D. Pessayre Acute and chronic steatosis lead to in vivo lipid peroxidation in mice J. Hepatol. 24 1996 200-208
184. P. Lettéron A. Sutton A. Mansouri B. Fromenty D. Pessayre Inhibition of microsomal triglyceride transfer protein: Another mechanism for drug-induced steatosis in mice Hepatology 38 2003 133-140
185. Y. Li T.T. Huang E.J. Carlson S. Melov P.C. Ursell J.L. Olson L.J. Noble M.P. Yoshimura C. Berger P.H. Chan D.C. Wallace C.J. Epstein Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase Nat. Genet. 11 1995 376-381
186. Y.Y. Li D. Chen S.C. Watkins A.M. Feldman Mitochondrial abnormalities in tumor necrosis factor-α-induced heart failure are associated with impaired DNA repair activity Circulation 104 2001 2492-2497
187. Z. Li S. Yang H. Lin J. Huang P.A. Watkins A.B. Moser C. Desimone X.Y. Song A.M. Diehl Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 2003 343-350
188. P. Liang V. Hughes N.K. Fukagawa Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance. Possible marker of glycemic stress Diabetes 46 1997 920-923
189. L.J. Liang X.Y. Yin S.M. Luo J.F. Zheng M.D. Lu J.F. Huang A study of the ameliorating effects of carnitine on hepatic steatosis induced by total parenteral nutrition in rats World J. Gastroenterol. 5 1999 312-315
190. W. Liao S.C.J. Yeung L. Chan Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplamic reticulum J. Biol. Chem. 273 1998 27225-27230
191. J. Licinio S. Caglayan M. Ozata B.O. Yildiz P.B. de Miranda F. O'Kirwan R. Whitby L. Liang P. Cohen S. Bhasin R.M. Krauss J.D. Veldhuis A.J. Wagner A.M. DePaoli S.M. McCann M.L. Wong Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults Proc. Natl Acad. Sci. USA 101 2004 4531-4536
192. M.C. Lin J.J. Li E.J. Wang G.L. Princler F.C. Kauffman H.F. Kung Ethanol down-regulates the transcription of microsomal triglyceride transfer protein gene Fed. Am. Soc. Exp. Biol. J. 11 1997 1145-1152
193. H.Z. Lin S.Q. Yang C. Chuckaree F. Kuhajda G. Ronnet A.M. Diehl Metformin reverses fatty liver disease in obese leptin-deficient mice Nat. Med. 6 2000 998-1003
194. K.D. Lindor K.V. Kowdley E.J. Heathcote M.E. Harrison R. Jorgensen P. Angulo J.F. Lymp L. Burgart P. Colin Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial Hepatology 39 2004 770-778
195. P.A. Lochhead I.P. Salt K.S. Walker D.G. Hardie C. Sutherland 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase Diabetes 49 2000 896-903
196. J.F. Louet F. Chatelain J.F. Decaux E.A. Park C. Kohl T. Pineau J. Girard J.P. Pegorier Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome proliferator-activated receptor-α (PPARα)-independent pathway Biochem. J. 354 2001 189-197
197. J.F. Louet G. Hayhurst F.J. Gonzalez J. Girard J.F. Decaux The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4α and cAMP-response element-binding protein (CREB) J. Biol. Chem. 277 2002 37991-38000
198. B.B. Lowell G.I. Shulman Mitochondrial dysfunction and type 2 diabetes Science 307 2005 384-387
199. C. Maisonneuve A. Igoudjil K. Begriche P. Lettéron M.C. Guimont J. Bastin J.P. Laigneau D. Pessayre B. Fromenty Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting Antivir. Ther. 9 2004 801-810
200. F.P. Mancini A. Lanni L. Sabatino M. Moreno A. Giannino F. Contaldo V. Colantuoni F. Goglia Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats Fed. Eur. Biochem. Soc. Lett. 491 2001 154-158
201. A. Mansouri B. Fromenty A. Berson M.A. Robin S. Grimbert M. Beaugrand S. Erlinger D. Pessayre Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patient J. Hepatol. 27 1997 96-102
202. A. Mansouri I. Gaou C. de Kerguenec S. Amsellem D. Haouzi A. Berson A. Moreau G. Feldmann P. Lettéron D. Pessayre B. Fromenty An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice Gastroenterology 117 1999 181-190
203. A. Mansouri C. Demeilliers S. Amsellem D. Pessayre B. Fromenty Acute ethanol administration oxidatively damages and depletes mitochondrial dna in mouse liver, brain, heart, and skeletal muscles: Protective effects of antioxidants J. Pharmacol. Exp. Ther. 298 2001 737-743
204. G. Marchesini M. Brizi G. Bianchi S. Tomassetti M. Zoli N. Melchionda Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893-894
205. G. Marchesini E. Bugianesi G. Forlani F. Cerrelli M. Lenzi R. Manini S. Natale E. Vanni N. Villanova N. Melchionda M. Rizzetto Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome Hepatology 37 2003 917-923
206. A.M. Martin E. Hammond D. Nolan C. Pace M. Den Boer L. Taylor H. Moore O.P. Martinez F.T. Christiansen S. Mallal Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors Am. J. Hum. Genet. 72 2003 549-560
207. T. Masaki S. Chiba H. Tatsukawa T. Yasuda H. Noguchi M. Seike H. Yoshimatsu Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice Hepatology 40 2004 177-184
208. T. Matsuhashi X. Liu Y. Nishizawa J. Usukura M. Wozniak T. Wakabayashi Mechanism of the formation of megamitochondria in the mouse liver induced by chloramphenicol Toxicol. Lett. 86 1996 47-54
209. K. Matsusue M. Haluzik G. Lambert S.H. Yim O. Gavrilova J.M. Ward B. Brewer M.L. Reitman F.J. Gonzalez Liver specific disruption of PPAR-γ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes J. Clin. Invest. 111 2003 737-747
210. T.C. McCarthy P.T. Pollak E.A. Hanniman C.J. Sinal Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-α target gene activation J. Pharmacol. Exp. Ther. 311 2004 864-873
211. G. McComsey R.K. Bai J.F. Maa D. Seekins L.J. Wong Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: Beyond mitochondrial DNA depletion J. Acquir Immun. Defic. Syndr. 39 2005 181-188
212. J.D. McGarry D.W. Foster Regulation of hepatic fatty acid oxidation and ketone body production Ann. Rev. Biochem. 49 1980 395-420
213. S. Melov J.A. Schneider B.J. Day D. Hinerfeld P. Coskun S.S. Mirra J.D. Crapo D.C. Wallace A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase Nat. Genet. 18 1998 159-163
214. R.A. Memon L.H. Tecott K. Nonogaki A. Beigneux A.H. Moser C. Grunfeld K.R. Feingold Up-regulation of peroxisome proliferator-activated receptors (PPAR-α) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity: Troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice Endocrinology 41 2000 4021-4031
215. S. Merat R. Malekzadeh M.R. Sohrabi M. Sotoudeh N. Rakhshani A.A. Sohrabpour S. Naserimoghadam Probucol in the treatment of non-alcoholic steatohepatitis: A double-blind randomized controlled study J. Hepatol. 38 2003 414-418
216. A. Moncion N.T. Truong A. Garrone P. Beaune R. Barouki I. De Waziers Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin J. Biol. Chem. 277 2002 45904-45910
217. S. Mori N. Morisaki Y. Saito S. Yoshida Age-related changes of long-chain fatty acid metabolism in rat liver Mech. Ageing Dev. 44 1988 175-183
218. G. Moyle Toxicity of antiretroviral nucleoside and nucleotide analogues. Is mitochondrial toxicity the only mechanism? Drug Saf. 23 2000 467-481
219. J. Müller-Höcker D. Aust H. Rohrbach J. Napiwotzky A. Reith T.A. Link P. Seibel D. Holzel B. Kadenbach Defects of the respiratory chain in the normal human liver and in cirrhosis during aging Hepatology 26 1997 709-719
220. M.R. Munday M.R. Milic S. Takhar M.J. Holness M.C. Sugden The short-term regulation of hepatic acetyl-CoA carboxylase during starvation and re-feeding in the rat Biochem. J. 280 1991 733-737
221. N. Musi M.F. Hirshman J. Nygren M. Svanfeldt P. Bavenholm O. Rooyackers G. Zhou J.M Williamson O. Ljunqvist S. Efendic D.E. Moller A. Thorell L.J. Goodyear Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes Diabetes 51 2002 2074-2081
222. N. Musi H. Yu L.J. Goodyear AMP-activated protein kinase regulation and action in skeletal muscle during exercise Biochem. Soc. Trans. 31 2003 191-195
223. G. Musso R. Gambino F. De Michieli M. Cassader M. Rizzetto M. Durazzo E. Faga B. Silli G. Pagano Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis Hepatology 37 2003 909-916
224. Y. Nagai Y. Nishio T. Nakamura H. Maegawa R. Kikkawa A. Kashiwagi Amelioration of high fructose-induced metabolic derangements by activation of PPARα Am. J. Physiol. Endocrinol. Metab. 282 2002 E1180-E1190
225. Y. Nagakawa G.M. Williams Q. Zheng A. Tsuchida T. Aoki R.A. Montgomery A.S Klein Z. Sun Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: Role of TNF-α Hepatology 42 2005 208-215
226. P. Nahon A. Sutton D. Pessayre P. Rufat F. Degoul N. Ganne-Carrie M. Ziol N. Charnaux G. N'kontchou J.C. Trinchet L. Gattegno M. Beaugrand Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death Clin. Gastroenterol. Hepatol. 3 2005 292-298
227. T. Nakatani N. Tsuboyama-Kasaoka M. Takahashi S. Miura O. Ezaki Mechanism for peroxisome proliferator-activated receptor-α activator-induced up-regulation of UCP-2 mRNA in rodent hepatocytes J. Biol. Chem. 277 2002 9562-9569
228. S. Nemoto K. Takeda Z.X. Yu V.J. Ferrans T. Finkel Role of mitochondrial oxidants as regulators of cellular metabolism Mol. Cell Biol. 20 2000 7311-7318
229. B.A. Neuschwander-Tetri S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD single topic conference Hepatology 37 2003 1202-1219
230. B.A. Neuschwander-Tetri E. Brunt K.R. Wehmeier D. Oliver B.R. Bacon Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone Hepatology 38 2003 1008-1017
231. H. Nohl L. Gille K. Staniek Intracellular generation of reactive oxygen species by mitochondria Biochem. Pharmacol. 69 2005 719-723
232. R. Note C. Maisonneuve P. Lettéron G. Peytavin F. Djouadi A. Igoudjil M.C. Guimont M. Biour D. Pessayre B. Fromenty Mitochondrial and metabolic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments Antimicrob. Agents Chemother. 47 2003 3384-3392
233. Y. Ogawa Y. Murata T. Saibara A. Nishioka S. Kariya S. Yoshida Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate Oncol. Rep. 10 2003 1473-1478
234. D. O'Shea S.N. Davis R.B. Kim G.R. Wilkinson Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity Clin. Pharmacol. Ther. 56 1994 359-367
235. M.R. Owen E. Doran A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem. J. 348 2000 607-614
236. U. Ozcan Q. Cao E. Yilmaz A.H. Lee N.N. Iwakoshi E. Ozdelen G. Tuncman C. Gorgun L.H. Glimcher G.S. Hotamisligil Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 306 2004 457-461
237. C. Pagano G. Soardo W. Esposito F. Fallo L. Basan D. Donnini G. Federspil L.A. Sechi R. Vettor Plasma adiponectin is decreased in nonalcoholic fatty liver disease Eur. J. Endocrinol. 152 2005 113-118
238. H. Park V.K. Kaushik S. Constant M. Prentki E. Przybytkowski N.B. Ruderman A.K. Saha Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise J. Biol. Chem. 277 2002 32571-32577
239. M. Patel B.J. Day Metalloporphyrin class of therapeutic catalytic antioxidants Trends Pharmacol. Sci. 20 1999 359-364
240. J.M. Paterson N.M. Morton C. Fievet C.J. Kenyon M.C. Holmes B. Staels Metabolic syndrome without obesity: Hepatic overexpression of 11-β-hydroxysteroid dehydrogenase type 1 in transgenic mice Proc. Natl Acad. Sci. USA 101 2004 7088-7093
241. M. Pérez-Carreras P. Del Hoyo M.A. Martin J.C. Rubio A. Martin G. Castellano F. Colina J. Arenas J.A. Solis-Herruzo Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis Hepatology 38 2003 999-1007
242. G. Perlemuter A. Sabile P. Lettéron G. Vona A. Topilco Y. Chretien K. Koike D. Pessayre J. Chapman G. Barba C. Brechot Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: A model of viral-related steatosis Fed. Am. Soc. Exp. Biol. J. 16 2002 185-194
243. D. Pessayre B. Fromenty NASH: A mitochondrial disease J. Hepatol. 42 2005 928-940
244. D. Pessayre A. Mansouri D. Haouzi B. Fromenty Hepatotoxicity due to mitochondrial dysfunction Cell Biol. Toxicol. 15 1999 367-373
245. D. Pessayre A. Berson B. Fromenty A. Mansouri Mitochondria in steatohepatitis Semin. Liver Dis. 21 2001 57-69
246. D. Pessayre A. Mansouri B. Fromenty Mitochondrial dysfunction in steatohepatitis Am. J. Physiol. Gastrointest. Liver Physiol. 282 2002 G193-G199
247. K.F. Petersen S. Dufour D. Befroy R. Garcia G.I. Shulman Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N. Engl. J. Med. 350 2004 664-671
248. F. Petit B. Fromenty A. Owen J. Estaquier Mitochondria are sensors for HIV drugs Trends Pharmacol. Sci. 26 2005 258-264
249. K.G. Pinz S. Shibutani D.F. Bogenhagen Action of mitochondrial DNA polymerase γ at sites of base loss or oxidative damage J. Biol. Chem. 270 1995 9202-9206
250. K. Promrat G. Lutchman G.I. Uwaifo R.J. Freedman A. Soza T. Heller E. Doo M. Ghany A. Premkumar Y. Park T.J. Liang J.A. Yanovski D.E. Kleiner J.H. Hoofnagle A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis Hepatology 39 2004 188-196
251. G. Quash G. Fournet U. Reichert Anaplerotic reactions in tumor proliferation and apoptosis Biochem. Pharmacol. 66 2003 365-370
252. S. Ramesh A.J. Sanyal Evaluation and management of non-alcoholic steatohepatitis J. Hepatol. 42 2005 S2-S12
253. M.S. Rao K. Papreddy S. Musunuri A. Okonkwo Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor-α ligand in rats In Vivo 16 2002 145-152
254. V. Ratziu L. Bonyhay V. Di Martino F. Charlotte L. Cavallaro M.H. Sayegh-Tainturier P. Giral A. Grimaldi P. Opolon T. Poynard Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 2002 1485-1493
255. E. Ravussin A NEAT way to control weight Science 307 2005 530-531
256. E. Ravussin R.E. Pratley M. Maffei H. Wang J.M. Friedman P.H. Bennett C. Bogardus Relatively low plasma leptin concentrations precede weight gain in Pima Indians Nat. Med. 3 1997 238-240
257. H. Raza S.K. Prabu M.A. Robin N.G. Avadhani Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: Tissue specific variations and roles in oxidative stress Diabetes 53 2004 185-194
258. B.M. Rezk G.R. Haenen W.J. Van Der Vijgh A. Bast The extraordinary antioxidant activity of vitamin E phosphate Biochim. Biophys. Acta 1683 2004 16-21
259. C. Richter J.W. Park B.N. Ames Normal oxidative damage to mitochondrial and nuclear DNA is extensive Proc. Natl Acad. Sci. USA 85 1988 6465-6467
260. V.B. Ritov E.V. Menshikova J. He R.E. Ferrell B.H. Goodpaster D.E. Kelley Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes Diabetes 54 2005 8-14
261. E. Riu F. Bosch A. Valera Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver Proc. Natl Acad. Sci. USA 93 1996 2198-2202
262. E.A. Roberts Steatohepatitis in children Best Prac. Res. Clin. Gastroenterol. 16 2002 749-765
263. M.A. Robin H.K. Anandatheerthavarada J.K. Fang M. Cudic L. Otvos N.G. Avadhani Mitochondrial targeted cytochrome P450 2E (P450 MT5) contains an intact N terminus and requires mitochondrial specific transfer proteins for activity J. Biol. Chem. 276 2001 24680-24689
264. M.A. Robin H.K. Anandatheerthavarada G. Biswas N.B. Sepuri D.M. Gordon D. Pain N.G. Avadhani Bimodal targeting of microsomal CYP2E1 to mitochondrial through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation J. Biol. Chem. 277 2002 40583-40593
265. M.A. Robin C. Demeilliers A. Sutton V. Paradis C. Maisonneuve S. Dubois S. Poirel P. Lettéron D. Pessayre B. Fromenty Alcohol increases TNF-α and decreases NF-κB to activate hepatic apoptosis in genetically obese mice Hepatology 42 2005 1280-1290
266. C.M. Rodrigues X. Ma C. Linehan-Stieers G. Fan B.T. Kren C.J. Steer Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation Cell Death Differ. 6 1999 842-854
267. N. Ruderman M. Prentki AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome Nat. Rev. Drug Discov. 3 2004 340-351
268. N.B. Ruderman H. Park V.K. Kaushik D. Dean S. Constant M. Prentki A.K. Saha AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise Acta Physiol. Scand. 178 2003 435-442
269. D.S. Sachan T.H. Rhew R.A. Ruark Ameliorating effects of carnitine and its precursors on alcohol-induced fatty liver Am. J. Clin. Nutr. 39 1984 738-744
270. A.K. Saha P.R. Avilucea J.M. Ye M.M. Assifi E.W. Kraegen N.B. Ruderman Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo Biochem. Biophys. Res. Commun. 314 2004 580-585
271. J.G. Salway Metabolism at a Glance 1994 Blackwell Scientific Publications Oxford 28-78
272. V.T. Samuel Z.X. Liu X. Qu B.D. Elder S. Bilz D. Befroy A.J. Romanelli G.I. Shulman Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease J. Biol. Chem. 279 2004 32345-32353
273. E. Sanguino M. Ramon L. Michalik W. Wahli M. Alegret R.M. Sanchez M. Vazquez-Carrere J.C. Laguna Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPAR-α Biochem. Pharmacol. 67 2004 157-166
274. E. Santamaria M.A. Avila M.U. Latasa A. Rubio A. Martin-Duce S.C. Lu J.M. Mato F.J. Corrales Functional proteomics of nonalcoholic steatohepatitis: Mitochondrial proteins as targets of S-adenosylmethionine Proc. Natl Acad. Sci. USA 100 2003 3065-3070
275. A.J. Sanyal C. Campbell-Sargent F. Mirshahi W.B. Rizzo M.J. Contos R.K. Sterling V.A. Luketic M.L. Shiffman J.N. Clore Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183-1192
276. S.K. Satapathy S. Garg R. Chauhan P. Sakhuja V. Malhotra B.C. Sharma S.K. Sarin Beneficial effects of tumor necrosis factor-α inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis Am. J. Gastroenterol. 99 2004 1946-1952
277. D.B. Savage S. O'Rahilly Leptin: A novel therapeutic role in lipodystrophy J. Clin. Invest. 109 2002 1285-1286
278. N.K. Saxena K. Ikeda D.C. Rockey S.L. Friedman F.A. Anania Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice Hepatology 35 2002 762-771
279. R. Scatena P. Bottoni G.E. Martorana F. Ferrari P. De Sole C. Rossi B. Giardina Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: Biochemical and pharmacological implications Biochem. Biophys. Res. Commun. 319 2004 967-973
280. J.M. Schattenberg Y. Wang R. Singh R.M. Rigoli M.J. Czaja Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling J. Biol. Chem. 280 2005 9887-9894
281. E.A. Schon E. Bonilla S. DiMauro Mitochondrial DNA mutations and pathogenesis J. Bioenerg. Biomembr. 29 1997 131-149
282. K. Schoonjans B. Staels J. Auwerx The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation Biochim. Biophys. Acta 1302 1996 93-109
283. K. Schulze-Osthoff A.C. Bakker B. Vanhaesebroeck R. Beyaert W.A. Jacob W. Fiers Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation J. Biol. Chem. 267 1992 5317-5323
284. J.B. Schwimmer R. Deutsch J.B. Rauch C. Behling R. Newbury J.E. Lavine Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease J. Pediatr. 143 2003 500-505
285. D.W. Seccombe L. James P. Hahn E. Jones l-carnitine treatment in the hyperlipidemic rabbit Metabolism 36 1987 1192-1196
286. M.C. Semino-Mora M.E. Leon-Monzon M.C. Dalakas The effect of l -carnitine on the AZT-induced destruction of human myotubes. Part II: treatment with l-carnitine improves the AZT-induced changes and prevents further destruction Lab. Invest. 71 1994 773-781
287. D. Serra N. Casals G. Asins T. Royo C.J. Ciudad F.G. Hegardt Regulation of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase protein by starvation, fat feeding, and diabetes Arch. Biochem. Biophys. 307 1993 40-45
288. G. Serviddio J. Pereda F.V. Pallardo J. Carretero C. Borras J. Cutrin G. Vendemiale G. Poli J. Vina J. Sastre Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress Hepatology 39 2004 711-720
289. P.R. Shepherd B.B. Kahn Glucose transporters and insulin action. Implications for insulin resistance and diabetes mellitus N. Engl. J. Med. 341 1999 248-257
290. I. Shimomura Y. Bashmakov J.D. Horton Increased levels of nuclear SREBP-1c associated with fatty livers of two mouse models of diabetes mellitus J. Biol. Chem. 274 1999 30028-30032
291. L. Spahr F. Negro G. Leandro O. Marinescu K.J. Goodman L. Rubbia-Brandt M. Jordan A. Hadengue Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis Med. Sci. Monit. 9 2003 CR6-CR11
292. M. Spaniol R. Bracher H.R. Ha F. Follath S. Krahenbuhl Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria J. Hepatol. 35 2001 628-636
293. B.M. Spiegelman J.S. Flier Obesity and the regulation of energy balance Cell 104 2001 531-543
294. R. Sreekumar B. Rosado D. Rasmussen M. Charlton Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis Hepatology 38 2003 244-251
295. J. Stadler B.G. Bentz B.G. Harbrecht M. Di Silvio R.D. Curran T.R. Billiar R.A. Hoffman R.L. Simmons Tumor necrosis factor-α inhibits hepatocyte mitochondrial respiration Ann. Surg. 216 1992 539-546
296. G.R. Steinberg D.J. Dyck Development of leptin resistance in rat soleus muscle in response to high-fat diets Am. J. Physiol. Endocrinol. Metab. 279 2000 E1374-E1382
297. G.R. Steinberg M.L. Parolin G.J. Heigenhauser D.J. Dyck Leptin increases FA oxidation in lean but not obese human skeletal muscle: Evidence of peripheral leptin resistance Am. J. Physiol. Endocrinol. Metab. 283 2002 E187-E192
298. J. St-Pierre J.A. Buckingham S.J. Roebuck M.D. Brand Topology of superoxide production from different sites in the mitochondrial electron transport chain J. Biol. Chem. 277 2002 44784-44790
299. R.S. Strauss Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III) J. Pediatr. 134 1999 160-165
300. N. Suematsu H. Tsutsui J. Wen D. Kang M. Ikeuchi T. Ide S. Hayashidani T. Shiomi T. Kubota N. Hamasaki A. Takeshita Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes Circulation 107 2003 1418-1423
301. T. Sugimoto S. Yamashita M. Ishigami N. Sakai K. Hirano M. Tahara K. Matsumoto T. Nakamura Y. Matsuzawa Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats J. Hepatol. 36 2002 157-162
302. S.K. Suh B.L. Hood B.J. Kim T.P. Conrads T.D. Veenstra B.J. Song Identification of oxidized mitochondrial proteins in alcohol-exposed human hepatoma cells and mouse liver Proteomics 4 2004 3401-3412
303. H.B. Suliman K.E. Welty-Wolf M.S. Carraway D.A. Schwartz J.W. Hollingsworth C.A. Piantadosi Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. Coli Fed. Am. Soc. Exp. Biol. J. 19 2005 1531-1533
304. A. Sutton H. Khoury C. Prip-Buus C. Cepanec D. Pessayre F. Degoul The Ala-9Val dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria Pharmacogentics 13 2003 145-157
305. M. Suwa H. Nakano S. Kumagai Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles J. Appl. Physiol. 95 2003 960-968
306. C. Taghibiglou A. Carpentier S.C. Van Iderstine B. Chen D. Rudy A. Aiton G.F. Lewis Adeli, K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular apoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model J. Biol. Chem. 275 2000 8416-8425
307. M. Tang J.J. Potter E. Mezey Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation Biochem. Biophys. Res. Commun. 297 2002 906-911
308. M.J. Tapner B.E. Jones W.M. Wu G.C. Farrell Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injury J. Hepatol. 40 2004 454-463
309. M. Tiikkainen A.M. Hakkinen E. Korsheninnikova T. Nyman S. Makimattila H. Yki-Jarvinen Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes Diabetes 53 2004 2169-2176
310. Y. Toyoshima O. Gavrilova S. Yakar W. Jou S. Pack Z. Asghar M.B. Wheeler D. LeRoith Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes Endocrinology 146 2005 4024-4035
311. K. Tran G. Thorne-Tjomsland C.J. DeLong Z. Cui J. Shan L. Burton J.C. Jamieson Z. Yao Intracellular assembly of very low density lipoproteins containing apolipoprotein B100 in rat hepatoma McA-RH777 cells J. Biol. Chem. 277 2002 31187-31200
312. T.S. Tsao H.F. Lodish J. Fruebis ACRP30, a new hormone controlling fat and glucose metabolism Eur. J. Pharmacol. 440 2002 213-221
313. C. Tuquet J. Dupont A. Mesneau J. Roussaux Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria Cell Biol. Toxicol. 16 2000 207-219
314. I.V. Turko L. Li K.S. Aulak D.J. Stuehr J.Y. Chang F. Murad Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes J. Biol. Chem. 278 2003 33972-33977
315. R.H. Unger Hyperleptinemia. Protecting the heart from lipid overload Hypertension 45 2005 1031-1034
316. A. Uygun A. Kadayifci Z. Yesilova A. Erdil H. Yaman M. Saka M.S Deveci S. Bagci M. Gulsen N. Karaeren K. Dagalp Serum leptin levels in patients with nonalcoholic steatohepatitis Am. J. Gastroenterol. 95 2000 3584-3589
317. K.T. Uysal S.M. Wiesbrock M.W. Marino G.S. Hotamisligil Protection from obesity-induced insulin resistance in mice lacking TNF-α function Nature 389 1997 610-614
318. L. Valenti A.L. Fracanzani P. Dongiovanni G. Santorelli A. Branchi E. Taioli G. Fiorelli S. Fargion Tumor necrosis factor-α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 2002 274-280
319. J.P. Van Huyen A. Landau C. Piketty M.F. Belair D. Batisse G. Gonzalez-Canali L. Weiss R. Jian M.D Kazatchkine P. Bruneval Toxic effects of nucleoside reverse transcriptase inhibitors on the liver. Value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy Am. J. Clin. Pathol. 119 2003 546-555
320. I. Vanhorebeek R. De Vos D. Mesotten P.J. Wouters C. De Wolf-Peeters G. Van den Berghe Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients Lancet 365 2005 53-59
321. G. Velasco T. Gomez del Pulgar D. Carling M. Guzman Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components Fed. Eur. Biochem. Soc. Lett. 439 1998 317-320
322. L.W. Velsor M. Kovacevic M. Goldstein H.M. Leitner W. Lewis B.J. Day Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine Toxicol. Appl. Pharmacol. 199 2004 10-19
323. A.S. Vrablic C.D. Albright C.N. Craciunescu R.I. Salganik S.H. Zeisel Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes Fed. Am. Soc. Exp. Biol. J. 15 2001 1739-1744
324. R. Vuppalanchi S. Marri D. Kolwankar R.V. Considine N. Chalasani Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study J. Clin. Gastroenterol. 39 2005 237-242
325. T. Wakabayashi Megamitochondria formation. Physiology and pathology J. Cell Mol. Med. 6 2002 497-538
326. J.H. Walter l-Carnitine Arch. Dis. Child 74 1996 475-478
327. Z. Wang S.D. Hall J.F. Maya l Li A. Asghar J.C. Gorski Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans Br. J. Clin. Pharmacol. 55 2003 77-85
328. Y. Wei M.J. Pagliassotti Hepatospecific effects of fructose on c-jun NH2-terminal kinase: Implications for hepatic insulin resistance Am. J. Physiol. Endocrinol. Metab. 287 2004 E926-E933
329. M.D. Weltman G.C. Farrell P. Hall M. Ingelman-Sundberg C. Liddle Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis Hepatology 27 1998 128-133
330. I.V. West Radicals and oxidative stress in diabetes Diabet. Med. 17 2000 171-180
331. M.D. Williams H. Van Remmen C.C. Conrad T.T. Huang C.J. Epstein A. Richardson Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice J. Biol. Chem. 273 1998 28510-28515
332. W.W. Winder D.G. Hardie AMP-activated protein kinase, a metabolic master switch: Possible role in type 2 diabetes Am. J. Physiol. 277 1 Pt 1 1999 E1-E10
333. W.W. Winder B.F. Holmes D.S. Rubink E.B. Jensen M. Chen J.O. Holloszy Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle J. Appl. Physiol. 88 2000 2219-2226
334. D. Wu A.I. Cederbaum Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: Role of CYP2E1 and mitochondria Hepatology 35 2002 1420-1430
335. A. Xu Y. Wang H. Keshaw L.Y. Xu K.S. Lam G.J. Cooper The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice J. Clin. Invest. 112 2003 91-100
336. S. Yamagishi D. Edelstein X. Du Y. Kaneda M. Guzman M. Brownlee Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A J. Biol. Chem. 276 2001 25096-25100
337. T. Yamauchi J. Kamon Y. Minokoshi Y. Ito H. Waki S. Uchida S. Yamashita M. Noda S. Kita K. Ueki K. Eto Y. Akanuma P. Froguel F. Foufelle P. Ferre D. Carling S. Kimura R. Nagai B.B. Kahn T. Kadowaki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat. Med. 8 2002 1288-1295
338. S.Q. Yang H. Zhu Y. Li H. Lin K. Gabrielson M.A. Trush A.M. Diehl Mitochondrial adaptations to obesity-related oxidant stress Arch. Biochem. Biophys. 378 2000 259-268
339. M. Yin E. Gäbele M.D. Wheeler H. Connor B.U. Bradford A. Dikalova I. Rusyn R. Mason R.G. Thurman Alcohol-induced free radicals in mice: direct toxicants or signaling molecules? Hepatology 34 2001 935-942
340. M. You M. Matsumoto C.M. Pacold W.K. Cho D.W. Crabb The role of AMP-activated protein kinase in the action of ethanol in the liver Gastroenterology 127 2004 1798-1808
341. T. Young C.C. Cunningham S.M. Bailey Reactive oxygen species production by the mitochondrial respiratory chain in isolated rat hepatocytes and liver mitochondria: Studies using myxothiazol Arch. Biochem. Biophys. 405 2002 65-72
342. Z.M. Younossi A. Baranova K. Ziegler L. Del Giacco K. Schlauch T.L. Born H. Elariny F. Gorreta A. VanMeter A. Younoszai J.P. Ong Z. Goodman V. Chandhoke A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease Hepatology 42 2005 665-674
343. S.P. Zhao H.J. Ye H.N. Zhou S. Nie Q.Z. Li Gemfibrozil reduces release of tumor necrosis factor-α in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease Clin. Chim. Acta 332 2003 61-67
344. G. Zhou R. Myers Y. Li Y. Chen X. Shen J. Fenyk-Melody M. Wu J. Ventre T. Doebber N. Fujii N. Musi M.F. Hirshman L.J. Goodyear D.E. Moller Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167-1174
345. M.H. Zou S.S. Kirkpatrick B.J. Davis J.S. Nelson W.G. Wiles U. Schlattner D. Neumann M. Brownlee M.B. Freeman M.H. Goldman Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species J. Biol. Chem. 279 2004 43940-43951